PEOPLE ON THE MOVE
XBiotech
Antibody-maker XBiotech has hired a former Amgen manufacturing expert.
Kelly Thornburg joins the company as Senior VP of Operations following 16 years at Amgen in senior quality control and manufacturing positions. During his time there, Thornburg contributed to the approval of the protein therapies Kineret (anakinra), Kepivance (palifermin), Nplate (romiplostim), and Prolia (denosumab).
In his new role, Thornburg will oversee manufacturing operations for the company’s ‘True Human’ therapeutic antibodies, including construction of XBiotech's commercial manufacturing facility.
The firm’s Abs are cloned directly from individual donors with natural immunity against certain diseases. XBiotech claims this makes the therapies uniquely safe and effective.
